The enhancement of vincristine cytotoxicity by combination with feselol

Journal of Asian Natural Products Research

Volumn 12, Issue 7, 2010, Pages 569-575

  Mollazadeh, Samaneh ^a   Matin, Maryam M ^a   Iranshahi, Mehrdad ^b   Bahrami, Ahmad Reza ^a   Neshati, Vajiheh ^a   Behnam Rassouli, Fatemeh ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ferula badrakema; feselol; sesquiterpene coumarin; TCC cells; vincristine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COUMARIN DERIVATIVE; FESELOL; GLYCOPROTEIN P; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; DRUG ISOLATION; FERULA BADRAKEMA; FRUIT; HUMAN; HUMAN CELL; TRANSITIONAL CELL CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, NEOPLASM; FERULA; FRUIT; HUMANS; MOLECULAR STRUCTURE; P-GLYCOPROTEIN; SESQUITERPENES; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VINCRISTINE;

FERULA;

EID: 77954745035     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2010.485565     Document Type: Article

References (24)

1. D. Chopin, R. Barei-Moniri, P. Maille, M.I. Frere-Belda, B. Muscatelli-Groux, and N. Merendino, Pathology 162, 1139 (2003).
2. C. Sternberg, A. Yagoda, H. Scher, R. Watson, N. Geller, and H. Herr, Cancer 64, 2448 (1989).
3. N. Sengupta, E. Siddiqui, and F.H. Mumtaz, J. R. Soc. Promot. Health 124, 228 (2004).
4. R. Dhamodharan, M.A. Jondan, D. Thrower, and L. Wilson, Mol. Biol. Cell 6, 1215 (1995).
5. D. Yu, S. Chang, and C.P. Ma, Br. J. Urol. 81, 234 (1998).
6. C. Wu, W. Zhang, J. Chang, Z. Zhao, G. Sun, and R. Han, Chin. J. Clin. Oncol. 3, 191 (2006).
7. D. French, Ethnobothany of the Umbelliferae (Academic Press, London, 1971).
8. M. Iranshahi, P. Arfa, M. Ramezani, M.R. Jaafari, H. Sadeghian, C. Bassarello, S. Piacente, and C. Pizza, Phytochemistry 68, 103 (2007).
9. M. Iranshahi, F. Kalategi, R. Rezaee, A.R. Shahverdi, C. Ito, H. Furukawa, H. Tokuda, and M. Itoigawa, Planta Med. 74, 147 (2008).
10. C. Barthomeuf, S. Lim, M. Iranshai, and P. Chollet, Phytomedicine 15, 103 (2008).
11. K.H. Rechinger, J.M. Lemond, and I.C. Hedge, Akademischev Druk-u. Verlagsanstalt, Graz 162, 269 (1994).
12. T.V. Bukreeva and M.G. Pimenov, Khim. Prir. Soedin. 27, 718 (1991).
13. C. Barthomeuf, M. Demeule, J. Grassi, A. Saidkhodjaev, and R. Beliveau, Planta Med. 72, 634 (2006).
14. V. Neshati, M.M. Matin, M. Iranshahi, A.R. Bahrami, J. Behravan, S. Mollazadeh, and F. Behnam Rassouli, Z. Naturforsch. C 64, 317 (2009).
15. F. Behnam-Rassouli, M.M. Matin, M. Iranshahi, A.R. Bahrami, V. Neshati, S. Mollazadeh, and Z. Neshati, Phytomedicine 16, 181 (2009).
16. J.M. Ford and W.N. Hait, Pharmacol. Rev. 42, 155 (1990).
17. D.L. Wu, F. Huang, and H.Z. Lu, Ai Zheng 22, 441 (2003).
18. S. Nobili, I. Landini, B. Giglioni, and E. Mini, Curr. Drug Targets 7, 861 (2006).
19. D.R. Hipfner, R.G. Deeley, and S.P. Cole, Biochem. Biophys. Acta 1461, 359 (1999).
20. C. Barthomeuf, J. Grassi, M. Demeule, C. Fournier, D. Boivin, and R. Beliveau, Cancer Chemother. Pharmacol. 56, 173 (2005).
21. F. Munoz-Martinez, C. Mendoza, I.L. Bazzocchi, S. Castanys, I.A. Jimenez, and F. Gamarro, J. Med. Chem. 48, 4266 (2005).
22. E. Lee and T.J. Marby, J. Nat. Prod. 48, 326 (1985).
23. M.H. Abd El-Razek, S. Ohta, and T. Hirata, Heterocycles 60, 689 (2003).
24. T. Mosmann, J. Immunol. Methods 65, 55 (1983).